Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Foley

Showing results (631-640 of 679) with videos related to

Pageof 68
Sort By:
Cancer Letters|April 9, 2025
Chaperone directed heterobifunctional molecules circumvent KRAS<sup>G12C</sup> inhibitor resistanceInes Pulido, Qiyue Luan, Sara Pastor-Puente, et al.
Blood|July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemiasHima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Surgery|October 18, 2011
Donation after cardiac death: a 29-year experienceJanet M Bellingham, Chandrasekar Santhanakrishnan, Nikole Neidlinger, et al.
Circulation|November 28, 2001
Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)M A Costa, R G Carere, S V Lichtenstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2018
Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation StudySimon J Walsh, Colm G Hanratty, Stuart Watkins, et al.
Cell Host & Microbe|April 13, 2018
Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage DysfunctionNetusha Thevaranjan, Alicja Puchta, Christian Schulz, et al.
Molecular Cancer Therapeutics|October 23, 2025
Dual Inhibitors of KRASG12D and HSP90 are Effective Against KRASG12D Inhibitor ResistanceInés Pulido, Laura C Gunder, Chenghao Ying, et al.
Journal of the American College of Cardiology|February 2, 2002
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) studyPatrick W Serruys, David P Foley, Martin Jan Suttorp, et al.
Clinical Spine Surgery|March 27, 2024
A Mechanistic and Preclinical Assessment of BioRestore Bioactive Glass as a Synthetic Bone Graft Extender and Substitute for Osteoinduction and Spine FusionElianna J Fred, Silvia Minardi, Alyssa M Goodwin, et al.
Journal of the American College of Cardiology|June 11, 2013
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patientsDavid Erlinge, Paul A Gurbel, Stefan James, et al.
Pageof 68

Showing results (631-640 of 679) with videos related to

Sort By:
Pageof 68
Cancer Letters|April 9, 2025
Chaperone directed heterobifunctional molecules circumvent KRAS<sup>G12C</sup> inhibitor resistanceInes Pulido, Qiyue Luan, Sara Pastor-Puente, et al.
Blood|July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemiasHima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Surgery|October 18, 2011
Donation after cardiac death: a 29-year experienceJanet M Bellingham, Chandrasekar Santhanakrishnan, Nikole Neidlinger, et al.
Circulation|November 28, 2001
Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS)M A Costa, R G Carere, S V Lichtenstein, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 25, 2018
Culotte stenting for coronary bifurcation lesions with 2nd and 3rd generation everolimus-eluting stents: the CELTIC Bifurcation StudySimon J Walsh, Colm G Hanratty, Stuart Watkins, et al.
Cell Host & Microbe|April 13, 2018
Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage DysfunctionNetusha Thevaranjan, Alicja Puchta, Christian Schulz, et al.
Molecular Cancer Therapeutics|October 23, 2025
Dual Inhibitors of KRASG12D and HSP90 are Effective Against KRASG12D Inhibitor ResistanceInés Pulido, Laura C Gunder, Chenghao Ying, et al.
Journal of the American College of Cardiology|February 2, 2002
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) studyPatrick W Serruys, David P Foley, Martin Jan Suttorp, et al.
Clinical Spine Surgery|March 27, 2024
A Mechanistic and Preclinical Assessment of BioRestore Bioactive Glass as a Synthetic Bone Graft Extender and Substitute for Osteoinduction and Spine FusionElianna J Fred, Silvia Minardi, Alyssa M Goodwin, et al.
Journal of the American College of Cardiology|June 11, 2013
Prasugrel 5 mg in the very elderly attenuates platelet inhibition but maintains noninferiority to prasugrel 10 mg in nonelderly patients: the GENERATIONS trial, a pharmacodynamic and pharmacokinetic study in stable coronary artery disease patientsDavid Erlinge, Paul A Gurbel, Stefan James, et al.
Pageof 68